News for ZTS Stock

Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results Zoetis Releases 2024 Sustainability Progress Update Dr. Mark Stetter Elected to Zoetis Board of Directors Zoetis Declares Third Quarter 2025 Dividend Zoetis to Participate in Upcoming Investor Conferences Zoetis Announces First Quarter 2025 Results Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results Zoetis to Participate in Upcoming Investor Conferences Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus Zoetis Reports Fourth Quarter and Full Year 2024 Results Zoetis Declares Second Quarter 2025 Dividend Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role Zoetis to Participate in Jefferies London Healthcare Conference Zoetis Announces Third Quarter 2024 Results Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products Zoetis Declares Fourth Quarter 2024 Dividend Zoetis and Danone Announce Strategic Partnership to Pioneer Sustainable Innovation in Dairy Farming Using the Power of Genetics Zoetis to Host Webcast and Conference Call on Third Quarter 2024 Financial Results Zoetis to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Zoetis Announces Second Quarter 2024 Results Zoetis Announces Authorization of Multi-Year $6 Billion Share Repurchase Program Zoetis Announces Time Change for Second Quarter 2024 Financial Results Webcast and Conference Call Zoetis to Host Webcast and Conference Call on Second Quarter 2024 Financial Results Zoetis Foundation and Zoetis Deepen Commitment to Global Disaster Relief with American Red Cross and American Humane Zoetis Releases 2023 Sustainability Report to Share Progress in Building a Better Future for Communities, Animals and the Planet Zoetis Declares Third Quarter 2024 Dividend Zoetis to Participate in the William Blair 44th Annual Growth Stock Conference Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference Zoetis Announces First Quarter 2024 Results Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health Zoetis Foundation Champions Global Veterinarian Education, Well-being, and Livelihoods on World Veterinary Day and Beyond Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors Zoetis to Host Webcast and Conference Call on First Quarter 2024 Financial Results Zoetis to Participate in the Barclays Global Healthcare Conference Zoetis to Participate in the Bank of America Securities 2024 Animal Health Summit Zoetis Reports Fourth Quarter and Full Year 2023 Results Zoetis Declares Second Quarter 2024 Dividend Zoetis Wins 2024 Catalyst Award 2024 Feather in Her Cap and High Flyer Award Winners Named for Outstanding Achievements in Animal Health Industry Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2023 Financial Results Zoetis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference Petco Love Announces Newest Board Members Zoetis Announces Third Quarter 2023 Results Zoetis Declares Fourth Quarter 2023 Dividend Zoetis Named a 100 Best Company for Working Parents by Seramount Zoetis to Host Webcast and Conference Call on Third Quarter 2023 Financial Results Zoetis Foundation Announces $2.6 Million in Grants to Advance Opportunities for Veterinarians and Livestock Farmers Zoetis to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference Zoetis Welcomes Officials to Celebrate New R&D Building in Durham, N.C. Media Advisory: Ribbon-cutting Ceremony for new Zoetis facility in Durham, N.C., to expand diagnostics R&D and engineering capabilities and bring more jobs to Durham Zoetis Welcomes Officials to Open New State-of-the-Art Facility in Lincoln Zoetis Announces Second Quarter 2023 Results Media Advisory: Ribbon Cutting Ceremony for new Zoetis facility in Lincoln, NE, to expand manufacturing capabilities and bring more jobs to Lincoln Zoetis Announces Appointment of Ester Banque as President of U.S. Operations for World Leader in Animal Health Zoetis to Host Webcast and Conference Call on Second Quarter 2023 Financial Results Zoetis Releases 2022 Sustainability Report to Share Progress in Building a Better Future for People, Animals and the Planet Zoetis to Participate in the Stifel 2023 Jaws and Paws Conference Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade JAB’s Pet Insurance Platform Acquires Pumpkin, Expanding its Global Leadership in the Fast-Growing Pet Insurance Industry Zoetis Declares Third Quarter 2023 Dividend Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs Zoetis Announces First Quarter 2023 Results Zoetis Announces Date for 2023 Investor Day Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-being Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results Zoetis Named One of the World’s Most Ethical Companies by Ethisphere Zoetis to Participate in the TD Cowen Health Care Conference Zoetis Secures $15.3 Million Grant to Advance Sustainable Livestock Production and Improve Livelihoods in Sub-Saharan Africa Zoetis to Participate in the Bank of America Securities 2023 Animal Health Summit Zoetis Reports Fourth Quarter and Full Year 2022 Results Zoetis Declares Second Quarter 2023 Dividend Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2022 Financial Results Zoetis to Participate in the 41st Annual J.P. Morgan Healthcare Conference Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase Zoetis to Participate in the Piper Sandler 34th Annual Healthcare Conference Zoetis Announces Pricing of $1.35 Billion of Senior Notes Zoetis Announces Third Quarter 2022 Results Vyond’s Latest Intelligent Video Creation Software Release Improves Stakeholder Engagement and Drives Business Outcomes Zoetis Declares Fourth Quarter 2022 Dividend Zoetis Named to Fortune’s 2022 Change the World List Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Zoetis Announces Second Quarter 2022 Results Zoetis Appoints Vanessa Broadhurst to its Board of Directors Zoetis to Host Webcast and Conference Call on Second Quarter 2022 Financial Results Zoetis Completes Acquisition of Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference Zoetis Releases 2021 Sustainability Update to Share Progress in Championing Healthier Communities, Animals and the Planet Zoetis Announces Agreement to Acquire Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions Zoetis to Participate in the Stifel 2022 Jaws and Paws Conference Zoetis Declares Third Quarter 2022 Dividend Zoetis Announces First Quarter 2022 Results Zoetis Foundation Announces First Round of 2022 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Wellness Zoetis to Host Webcast and Conference Call on First Quarter 2022 Financial Results Zoetis to Participate in the Barclays Global Healthcare Conference Zoetis Named One of Most Innovative Companies in 2022 by Fast Company Zoetis to Participate in the Bank of America Securities 2022 Animal Health Summit Zoetis Reports Fourth Quarter and Full Year 2021 Results Zoetis Declares Second Quarter 2022 Dividend Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats Zoetis Announces Expanded Commitments to Protect the Planet Zoetis to Participate in the 40th Annual J.P. Morgan Healthcare Conference Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financial Results Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program Zoetis Named One of Newsweek’s Most Responsible Companies for 2022 Zoetis Announces Third Quarter 2021 Results Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health Zoetis Declares Fourth Quarter 2021 Dividend Zoetis to Host Webcast and Conference Call on Third Quarter 2021 Financial Results Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount Zoetis to Participate in the Jefferies Virtual Pet Care Summit Zoetis Announces Second Quarter 2021 Results Zoetis to Acquire Jurox, a Leading Provider and Manufacturer of Livestock and Companion Animal Products Zoetis Donates COVID-19 Vaccines to Help Support the Health of Zoo Animals Zoetis to Host Webcast and Conference Call on Second Quarter 2021 Financial Results Zoetis A.L.P.H.A. Initiative Improves Livestock Health and Farmers’ Livelihoods in Sub-Saharan Africa with 1.7 billion Doses of Vaccines and Medicines administered in Four Years Zoetis Releases 2020 Sustainability Report and Creates the Zoetis Foundation, Marking Progress in Creating a Healthier Future for Communities, Animals and the Planet Zoetis to Participate in the William Blair 41st Annual Growth Stock Conference Zoetis to Participate in the Stifel 2021 Virtual Jaws & Paws Conference Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2021 Dividend Zoetis Announces Appointment of Glenn David as Group President and Wetteny Joseph as Executive Vice President and Chief Financial Officer Zoetis Announces First Quarter 2021 Results Zoetis to Host Webcast and Conference Call on First Quarter 2021 Financial Results Zoetis Launches “Driven to Care” Sustainability Initiative and Long-Term Goals to Meet Commitments to Communities, Animals and the Planet Zoetis to Participate in the Cowen 41st Annual Health Care Conference Zoetis to Participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum Zoetis Receives European Commission Marketing Authorization for Solensia® (frunevetmab), a New Therapy for Feline Osteoarthritis Pain Zoetis Reports Fourth Quarter and Full Year 2020 Results Forbes Names Zoetis One of America’s Best Midsize Employers Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2020 Financial Results Zoetis to Participate in the 39th Annual J.P. Morgan Healthcare Conference Zoetis Declares First Quarter 2021 Dividend; Board Approves 25% Payment Increase Zoetis Appoints Tonie Leatherberry to Its Board of Directors Zoetis Named One of the “Top 75 Companies for Executive Women” by Working Mother Media Zoetis is First Animal Health Company to Issue Environmental, Social and Governance (ESG) Review Based on Leading Sustainability Frameworks Zoetis to Participate in the Credit Suisse 2020 Virtual Healthcare Conference Zoetis Declares Fourth Quarter 2020 Dividend Zoetis to Host Webcast and Conference Call on Third Quarter 2020 Financial Results Trianni and Zoetis Announce Agreement to Develop a Transgenic Antibody Discovery Platform for Use in Animal Health